Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Erythema nodosum
ADR ID BADD_A01541
ADR Hierarchy
10      Immune system disorders
10.02      Immune disorders NEC
10.02.01      Immune and associated conditions NEC
10.02.01.020      Erythema nodosum
23      Skin and subcutaneous tissue disorders
23.07      Skin and subcutaneous tissue disorders NEC
23.07.02      Panniculitides
23.07.02.001      Erythema nodosum
Description An erythematous eruption commonly associated with drug reactions or infection and characterized by inflammatory nodules that are usually tender, multiple, and bilateral. These nodules are located predominantly on the shins with less common occurrence on the thighs and forearms. They undergo characteristic color changes ending in temporary bruise-like areas. This condition usually subsides in 3-6 weeks without scarring or atrophy. [MeSH]
MedDRA Code 10015226
MeSH ID D004893
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Erythema nodosum | Erythema nodosum-like lesion | Erythema Nodosum
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01309Lomefloxacin--
BADD_D01363Meclofenamate sodium--
BADD_D01365Medroxyprogesterone--
BADD_D01366Medroxyprogesterone acetate--
BADD_D01393Meropenem0.000073%
BADD_D01397Mesalamine0.000732%
BADD_D01418Methotrexate--
BADD_D01433Methylprednisolone--
BADD_D01463Mifepristone--
BADD_D01470Minocycline0.000295%
BADD_D01471Minocycline anion--
BADD_D01496Montelukast--
BADD_D01497Montelukast sodium--
BADD_D01513Nafarelin0.000279%
BADD_D01533Naproxen--
BADD_D01534Naproxen sodium--
BADD_D01557Nevirapine--
BADD_D01567Nilotinib0.000112%
BADD_D01585Norethindrone--
BADD_D01586Norethindrone acetate--
BADD_D01598Ofloxacin--
BADD_D01601Olaparib0.000168%
BADD_D01607Olsalazine--
BADD_D01608Olsalazine sodium--
BADD_D01679Paroxetine--
BADD_D01680Paroxetine hydrochloride--
BADD_D01681Paroxetine hydrochloride hemihydrate--
BADD_D01682Paroxetine impurity a--
BADD_D01683Paroxetine mesylate--
BADD_D01771Pilocarpine hydrochloride--
The 3th Page    First    Pre   3 4    Next   Last    Total 4 Pages